Rislenemdaz is primarily investigated for its potential therapeutic applications in the field of neurology, particularly in the treatment of neurodegenerative diseases. It is studied for its ability to modulate specific receptors in the brain, which may help in alleviating symptoms associated with conditions like Alzheimer’s disease and other forms of dementia. Additionally, its neuroprotective properties are being explored to understand its role in preventing or slowing down neuronal damage. Research is ongoing to determine its efficacy and safety in clinical settings, with a focus on its potential to improve cognitive function and memory in patients suffering from neurological disorders.